M. tuberculosis Pantothenate Kinase: Dual Substrate Specificity and Unusual Changes in Ligand Locations

Journal of Molecular Biology

Volumn 400, Issue 2, 2010, Pages 171-185

  Chetnani, Bhaskar ^a   Kumar, Parimal ^a   Surolia, A ^a,b   Vijayan, M ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

ATP and GTP; CoA biosynthesis pathway; Crystal structures; Productive and non productive binding; TB proteins

Indexed keywords

COENZYME A; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; PANTOTHENATE KINASE; PANTOTHENIC ACID;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME SPECIFICITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ESCHERICHIA COLI; MYCOBACTERIUM TUBERCULOSIS;

EID: 77953807959     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.04.064     Document Type: Article

References (37)

1. Leonardi R., Zhang Y.M., Rock C.O., Jackowski S. Coenzyme A: back in action. Prog. Lipid Res. 2005, 44:125-153.
2. Zhou B., Westaway S.K., Levinson B., Johnson M.A., Gitschier J., Hayflick S.J. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat. Genet. 2001, 28:345-349.
3. Zhang Y.M., Rock C.O., Jackowski S. Biochemical properties of human pantothenate kinase 2 isoforms and mutations linked to pantothenate kinase associated neurodegeneration. J. Biol. Chem. 2006, 281:107-114.
4. Yun M., Park C.G., Kim J.Y., Rock C.O., Jackowski S., Park H.W. Structural basis for the feedback regulation of Escherichia coli pantothenate kinase by coenzyme A. J. Biol. Chem. 2000, 275:28093-28099.
5. Ivey R.A., Zhang Y.M., Virga K.G., Henever K., Lee R.E., Rock C.O., et al. The structure of the pantothenate kinase·ADP·pantothenate ternary complex reveals the relationship between the binding sites for substrate, allosteric regulator, and antimetabolites. J. Biol. Chem. 2004, 279:35622-35629.
6. Vijayan M. Structural biology of mycobacterial proteins: the Bangalore effort. Tuberculosis 2005, 85:357-366.
7. Das S., Kumar P., Bhor V., Surolia A., Vijayan M. Invariance and variability in bacterial PanK: a study based on the crystal structure of Mycobacterium tuberculosis PanK. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2006, 62:628-638.
8. Krishna R., Prabu J.R., Manjunath G.P., Datta S., Chandra N.R., Muniyappa K., et al. Snapshots of RecA protein involving movement of C-domain and different conformations of the DNA-binding loops: crystallographic and comparative analysis of 11 structures of Mycobacterium smegmatis RecA. J. Mol. Biol. 2007, 367:1130-1144.
9. Selvaraj M., Roy S., Singh N.S., Sangeetha R., Varshney U., Vijayan M. Structural plasticity and enzyme action: crystal structures of Mycobacterium tuberculosis peptidyl-tRNA hydrolase. J. Mol. Biol. 2007, 372:186-193.
10. Roy S., Saraswathi R., Chatterji D., Vijayan M. Structural studies on the second Mycobacterium smegmatis Dps: invariant and variable features of structure, assembly and function. J. Mol. Biol. 2008, 375:948-959.
11. Chetnani B., Das S., Kumar P., Surolia A., Vijayan M. Mycobacterium tuberculosis pantothenate kinase: possible changes in location of ligands during enzyme action. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2009, 65:312-325.
12. Prabu J.R., Thamotharan S., Khanduja J.S., Chandra N.R., Muniyappa K., Vijayan M. Crystallographic and modeling studies on Mycobacterium tuberculosis RuvA. Additional role of RuvB-binding domain and inter species variability. Biochim. Biophys. Acta 2009, 1794:1001-1009.
13. Gopal B., Haire L.F., Cox R.A., Jo Colston M., Major S., Brannigan J.A., et al. The crystal structure of NusB from Mycobacterium tuberculosis. Nat. Struct. Biol. 2000, 7:475-478.
14. Terwilliger T.C. Structural genomics in North America. Nat. Struct. Biol. 2000, 7:935-939.
15. Murillo A.C., Li H.Y., Alber T., Baker E.N., Berget J.M., Cherney L.T., et al. High throughput crystallography of TB drug targets. Infect. Disord. Drug Targets 2007, 7:127-139.
16. Ioerger T.R., Sacchettini J.C. Structural genomics approach to drug discovery for Mycobacterium tuberculosis. Curr. Opin. Microbiol. 2009, 12:318-325.
17. Base D., Khare G., Singh S., Tyagi A., Khosla S., Mande S.C. A novel nucleoid-associated protein of Mycobacterium tuberculosis is a sequence homolog of GroEL. Nucleic Acids Res. 2009, 15:4944-4954.
18. Niefind K., Putter M., Guerra B., Issinger O.G., Schomburg D. GTP plus water mimic ATP in the active site of protein kinase CK2. Nat. Struct. Biol. 1999, 6:1100-1103.
19. Takagi M., Tamaki H., Miyamoto Y., Leonardi R., Hanada S., Jackowski S., et al. Pantothenate kinase from the thermoacidophilic archaeon Picrophilus torridus. J. Bacteriol. 2010, 192:233-241.
20. Sekine S., Nureli O., Dubois D.Y., Bernier S., Chenevert R., Lapointe J., et al. ATP binding by glutamyl-tRNA synthetase is switched to the productive mode by tRNA binding. EMBO J. 2003, 22:676-688.
21. Jauch R., Humm A., Huber R., Wahl M.C. Structures of Escherichia coli NAD synthetase with substrates and products reveal mechanistic rearrangements. J. Biol. Chem. 2005, 280:15131-15140.
22. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393:537-544.
23. Murphy D.J., Brown J.R. Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. BMC Infect. Dis. 2007, 7:84-100.
24. Deb C., Lee C.M., Dubey V.S., Daniel J., Abomoelak B., Sirakova T.D., et al. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded drug-tolerant, dormant pathogen. PLoS ONE 2009, 4:e6007.
25. Boshoff H.I., Barry C.E. Tuberculosis-metabolism and respiration in absence of growth. Nat. Rev., Microbiol. 2005, 3:70-80.
26. Shi L., Sohaskey C.D., Kana B.D., Dawes S., North R.J., Mizrahi V., Gennaro M.L. Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc. Natl Acad. Sci. USA 2005, 102:15629-15634.
27. Chene P. ATPase as drug targets: learning from their structure. Nat. Rev., Drug Discov. 2002, 1:665-673.
28. Das S., Kumar P., Bhor V., Surolia A., Vijayan M. Expression, purification, crystallization and preliminary X-ray crystallographic analysis of pantothenate kinase from Mycobacterium tuberculosis. Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun. 2005, 61:65-67.
29. Collaborative Computational Project, Number 4 The CCP4 suite: programs for protein crystallography. Acta Crystallogr., Sect. D: Biol. Crystallogr. 1994, 50:760-763.
30. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr., Sect. D: Biol. Crystallogr. 1998, 54:905-921.
31. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60:2126-2132.
32. SchǗttelkopf A.W., van Aalten D.M. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60:1355-1363.
33. Laskowski R.A., Moss D.S., Thornton J.M. Main-chain bond lengths and bond angles in protein structures. J. Mol. Biol. 1993, 231:1049-1067.
34. Davis I.W., Leaver-Fay A., Chen V.B., Block J.N., Kapral G.J., Wang X., et al. MolProbity: all-atom contact and structure validation for proteins and nucleic acids. Nucleic Acids Res. 2007, 35:W375-W383.
35. Kabsch W., Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983, 22:2577-2637.
36. Cohen G.E. ALIGN: a program to superimpose protein coordinates, accounting for insertions and deletions. J. Appl. Crystallogr. 1997, 30:1160-1161.
37. Delano W.L. The PyMOL Molecular Graphics Systems 2002, DeLano Scientific, San Carlos, CA.